Geng Li Selected Research

Xue-Fu-Zhu-Yu decoction

1/2021	Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): a study protocol for a randomized placebo-controlled trial.
1/2020	Chinese Herbal Formula Xuefu Zhuyu for Tension-Type Headache with Qi-Stagnation and Blood-Stasis Pattern (CheruXTH): Study Protocol for a Randomized Controlled Trial.
1/2020	Chinese Herbal Formula Xuefu Zhuyu for Stable Angina (CheruSA): Study Protocol for a Multicenter Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geng Li Research Topics

Disease

21	Neoplasms (Cancer) 11/2021 - 02/2002
14	Infections 12/2022 - 06/2003
8	Inflammation (Inflammations) 01/2022 - 12/2008
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2015
6	Sepsis (Septicemia) 01/2021 - 11/2004
5	Neoplasm Metastasis (Metastasis) 10/2021 - 09/2004
5	Carcinoma (Carcinomatosis) 09/2021 - 04/2002
5	Human Influenza (Influenza) 01/2021 - 03/2005
5	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
4	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2016 - 07/2014
3	Hypoxia (Hypoxemia) 01/2022 - 11/2017
3	Atherosclerosis 01/2022 - 01/2016
3	Acute Lung Injury 01/2022 - 01/2019
3	COVID-19 07/2021 - 01/2021
3	Zika Virus Infection 01/2020 - 01/2018
3	Edema (Dropsy) 01/2019 - 01/2017
3	Insulin Resistance 07/2017 - 06/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2012 - 02/2008
3	Stroke (Strokes) 01/2011 - 09/2006
3	Prostatic Neoplasms (Prostate Cancer) 06/2009 - 06/2003
2	Virus Diseases (Viral Diseases) 12/2022 - 07/2021
2	Stomach Neoplasms (Stomach Cancer) 09/2021 - 11/2002
2	Allergic Rhinitis 01/2021 - 01/2015
2	Birth Weight (Birth Weights) 01/2021 - 01/2019
2	Aortic Valve Disease 08/2020 - 08/2015
2	Pneumonia (Pneumonitis) 01/2019 - 01/2006
2	Heart Failure 01/2019 - 10/2017
2	Thrombosis (Thrombus) 10/2016 - 06/2007
2	Hyperplasia 12/2013 - 06/2009
2	Breast Neoplasms (Breast Cancer) 03/2013 - 09/2003
2	Reperfusion Injury 06/2010 - 09/2006
2	Amyloid Plaque 05/2010 - 02/2008
2	Necrosis 12/2008 - 02/2008
2	Atrophy 01/2008 - 06/2007
2	Infarction (Infarctions) 06/2007 - 09/2006
2	Testicular Neoplasms (Testicular Cancer) 02/2007 - 03/2004
1	Plasmacytoma 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Peroneal Neuropathies 12/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
11	CytokinesIBA 01/2022 - 04/2002
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2006
8	AntigensIBA 02/2007 - 04/2002
7	Messenger RNA (mRNA)IBA 12/2022 - 06/2002
6	Peptides (Polypeptides)IBA 10/2021 - 02/2002
5	InflammasomesIBA 12/2022 - 01/2018
4	LipopolysaccharidesIBA 01/2022 - 01/2019
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2006
4	VaccinesIBA 07/2021 - 03/2004
4	Biological ProductsIBA 01/2021 - 09/2003
4	coenzyme Q10 (CoQ10)IBA 05/2010 - 01/2005
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2006 - 04/2002
3	NF-kappa B (NF-kB)IBA 01/2022 - 12/2008
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2005
3	Xue-Fu-Zhu-Yu decoctionIBA 01/2021 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 05/2013 - 01/2005
3	Presenilin-1IBA 01/2012 - 01/2008
3	Amyloid beta-PeptidesIBA 05/2010 - 01/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 02/2007 - 02/2002
3	Complementary DNA (cDNA)IBA 03/2004 - 11/2002
2	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2017
2	Long Noncoding RNAIBA 01/2022 - 08/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2003
2	Polysaccharides (Glycans)IBA 01/2021 - 06/2007
2	Therapeutic UsesIBA 01/2020 - 07/2014
2	ChemokinesIBA 01/2019 - 06/2006
2	Hypoglycemic Agents (Hypoglycemics)IBA 07/2017 - 05/2009
2	Ointments (Pastes)IBA 07/2016 - 07/2014
2	calcipotriene (calcipotriol)FDA LinkGeneric 07/2016 - 07/2014
2	Betamethasone (Celestone)FDA Link 07/2016 - 07/2014
2	Insulin (Novolin)FDA Link 05/2013 - 06/2011
2	AdiponectinIBA 05/2013 - 05/2009
2	Amyloid (Amyloid Fibrils)IBA 05/2010 - 01/2008
2	HLA-DR Antigens (HLA-DR)IBA 01/2006 - 03/2005
2	C-Reactive ProteinIBA 01/2006 - 11/2004
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	CholesterolIBA 01/2022
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 11/2021
1	GadoliniumIBA 10/2021

Therapy/Procedure

15	Therapeutics 12/2022 - 02/2002
7	Immunotherapy 10/2021 - 04/2002
5	Lasers (Laser) 01/2017 - 09/2003
3	Knee Replacement Arthroplasty (Total Knee Replacement) 07/2020 - 09/2016
3	Acupuncture Points (Acupuncture Point) 01/2015 - 11/2006
2	Prostatectomy (Retropubic Prostatectomy) 04/2019 - 06/2009
2	Oral Administration 09/2014 - 05/2010
1	Denervation 12/2021